Search By

Format
Articles (153)Events (33)News (1095)Interviews (76)
Publication Date
Last 3 months Last 6 months Last 12 months All Time

1,095 Results

Search By

ArticlesEventsNewsInterviews

AI Murmur Detection Enters Veterinary Clinics via Boehringer-Eko Partnership

Boehringer Ingelheim and Eko Health launch AI cardiac tool for dogs, detecting murmurs with 95%+ sensitivity across US and UK clinics.

Pharma Now Editorial Team | Apr 29, 2026

Australia Validated for Trachoma Elimination, Joining 29 Nations

WHO validates Australia as the 30th country to eliminate trachoma, citing decades of community-integrated public health action.

Pharma Now Editorial Team | Apr 29, 2026

Skyrizi and Rinvoq Redefine AbbVie's Manufacturing Priorities

AbbVie's Q1 2026 immunology revenues hit $7.29B as Skyrizi and Rinvoq growth reshapes manufacturing and capacity priorities post-Humira.

Pharma Now Editorial Team | Apr 29, 2026

EMA's New Vaccine Confidence Panel Signals Tighter Benefit-Risk Communication Expectations

EMA launches a quarterly vaccine confidence advisory group, signalling closer scrutiny of benefit-risk communication and post-market obligations for vaccine manufacturers.

Pharma Now Editorial Team | Apr 29, 2026

Pharma Supply Chains Are Functional — But Optimisation Gaps Persist

LogiPharma data reveals pharma supply chains are operational but lack the visibility and collaboration needed for true resilience.

Pharma Now Editorial Team | Apr 29, 2026

Purdue Pharma's $5.5B Verdict Resets Compliance Stakes for Manufacturers

Purdue Pharma ordered to pay $5.5B in opioid ruling, raising the compliance bar for pharma manufacturers industry-wide.

Pharma Now Editorial Team | Apr 29, 2026

Teva Bets $700M on First-in-Class Tourette Therapy Ahead of NDA

Teva acquires Emalex for $700M, targeting a 2H 2026 NDA for ecopipam, a first-in-class D1 antagonist for pediatric Tourette syndrome.

Pharma Now Editorial Team | Apr 29, 2026